Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...

More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...

A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center ...

Denton groundbreaking is latest milestone in Novartis’ $23 billion investment in US research and manufacturing ...

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak ...

Medical professionals in Acadiana are utilizing low-dose radiation therapy as an innovative treatment for osteoarthritis, ...

Red-light therapy promises to treat everything from acne and hair loss to depression and chronic pain. Many of these claims ...

Colorectal cancer is on the rise in adults under 50. Shermeine Hammie’s story is a powerful reminder of how screenings save ...

We are now approaching the midpoint of the 2020s, and the pace of innovation in radiation oncology has never been greater. Advances in artificial ...

At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...

Gastrointestinal (GI) cancers present unique challenges for radiation oncologists due to tumor motion, anatomical variability, and the proximity of ...